Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid × Sorafenib × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 49 Carcinoma, Renal Cell 23 Liver Neoplasms 22 Neoplasms 18 Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Kidney Neoplasms 10 Leukemia, Myeloid, Acute 9 Melanoma 8 Sarcoma 7 Prostatic Neoplasms 7 Neoplasm Metastasis 6 Lung Neoplasms 6 Glioblastoma 6 Ovarian Neoplasms 5 Brain Neoplasms 5 Thyroid Neoplasms 4 Recurrence 4 Pancreatic Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leiomyosarcoma 3 Gliosarcoma 3 Gallbladder Neoplasms 3 Carcinoma 3

Interventions

Imatinib Mesylate 5 ponatinib 4 Cytarabine 4 venetoclax 3 nilotinib 3 Mycophenolic Acid 3 thymoglobulin 2 fludarabine phosphate 2 Lenalidomide 2 Cyclosporine 2 Cyclophosphamide 2 Antilymphocyte Serum 2 quizartinib 1 methanesulfonic acid 1 glasdegib 1 fludarabine 1 etoposide phosphate 1 enasidenib 1 daratumumab 1 bosutinib 1 asciminib 1 Whole-Body Irradiation 1 Transplantation 1 Temozolomide 1 Tacrolimus 1 Stem Cell Transplantation 1 Standard of Care 1 RFT5-SMPT-dgA immunotoxin 1 Peripheral Blood Stem Cell Transplantation 1 N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡